Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Preferred Equity

Aquestive Therapeutics Inc Preferred Equity Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Preferred Equity from 2006 to 2017.
  • Aquestive Therapeutics Inc Preferred Equity for the quarter ending December 12, 2017 was $81m a 52.06% increase of 42m year over year
  • Aquestive Therapeutics Inc Preferred Equity for the last 12 months ending December 12, 2017 was $81m a 52.06% increase of 42m year over year
  • Aquestive Therapeutics Inc Annual Preferred Equity for 2017 was $81m a 3.07% increase of 2m from 2016
  • Aquestive Therapeutics Inc Annual Preferred Equity for 2016 was $78m a 50.54% increase of 40m from 2015
  • Aquestive Therapeutics Inc Annual Preferred Equity for 2006 was $39m
Other Balance Sheet Metrics:
  • Aquestive Therapeutics Inc Total Assets for the quarter ending December 12, 2018 was $87m a 46.94% increase of 41m year over year
  • Aquestive Therapeutics Inc Other Liabilities for the quarter ending December 12, 2018 was $1m a -565.38% decrease of -7m year over year
  • Aquestive Therapeutics Inc Total Equity for the quarter ending December 12, 2018 was $10m a 322.18% increase of 32m year over year
View Chart On Koyfin

Quarterly AQST Preferred Equity Data

12/2017$81m
03/2017$78m
06/2007$39m
03/2007$39m
12/2006$39m
09/2006$39m

Annual AQST Preferred Equity Data

2017$81m
2016$78m
2006$39m